InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Quil-A® adjuvant | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |
| ODN 2006 (ODN 7909) | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |
| pINFUSE-hIgG2-Fc | Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement w... | 2022 | Nat Commun | Du Y. et al. | DOI: 10.1038/s41467-021-27936-8 |
| FSL-1 | C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and ... | 2022 | Nat Commun | Park I. et al. | DOI: 10.1038/s41467-021-27862-9 |
| LPS-EB VacciGrade™ | Suppression of lipopolysaccharide-induced corneal opacity by hepatocyte growt... | 2022 | Sci Rep | Elbasiony E. et al. | DOI: 10.1038/s41598-021-04418-x |
| Blasticidin | Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNB... | 2022 | Cell Death Dis. | Al Haq A.T. et al. | DOI: 10.1038/s41419-021-04486-x |
| G418 (Geneticin) | A new transgene mouse model using an extravesicular EGFP tag enables affinity... | 2022 | Sci Rep | Norgard M.O. et al. | DOI: 10.1038/s41598-021-04512-0 |
| Puromycin | The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor sup... | 2022 | Commun Biol | Machino H. et al. | DOI: 10.1038/s42003-021-02992-4 |
| Pam3CSK4 | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| ODN 2395 - TLR9 ligand | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| Imiquimod (R837) | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| FSL-1 | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| MDP | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| R848 (Resiquimod) | Alpha synuclein, the culprit in Parkinson disease, is required for normal imm... | 2022 | Cell Rep | Alam M.Met al. | DOI: 10.1016/j.celrep.2021.110090 |
| Normocin® - Antimicrobial Reagent | ATRX loss in glioma results in dysregulation of cell-cycle phase transition a... | 2022 | Cell Rep | Qin T. et al. | DOI: 10.1016/j.celrep.2021.110216 |
| Quil-A® adjuvant | Mannose-binding lectin and complement mediate follicular localization and enh... | 2022 | Cell Rep | Read B.J. etal. | DOI: 10.1016/j.celrep.2021.110217 |
| ISD | Reprogramming of nucleotide metabolism by interferon confers dependence on th... | 2022 | Cell Rep | Abt E.R. et al. | DOI: 10.1016/j.celrep.2021.110236 |
| 2’3’-cGAM(PS)2 (Rp/Sp) | Reprogramming of nucleotide metabolism by interferon confers dependence on th... | 2022 | Cell Rep | Abt E.R. et al. | DOI: 10.1016/j.celrep.2021.110236 |
| Puromycin | A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoti... | 2022 | Nat Commun | Pradella D. et al. | DOI: 10.1038/s41467-021-24998-6 |